Max Healthcare Institute Limited — Updates, 30-01-2025: Press Release

Max Healthcare reported robust performance for the third quarter and nine months ended December 2024. Network gross revenue hit INR 2,381 Cr, marking a 34% YoY increase and a 7% QoQ growth. Operating EBITDA increased by 32% YoY to reach INR 622 Cr, with an operating margin of 27.3%. Notably, PAT before exceptional items amounted to INR 390 Cr, reflecting a 15% YoY growth. The company's free cash flow from operations for the quarter was recorded at INR 303 Cr.

Strategically, Max Healthcare has taken significant steps, including the approval for a 500-bed hospital in Thane and expansion plans for a hospital in Zirakpur from 250 to 400 beds. The acquisition of Jaypee Healthcare Limited has also been completed. The network's strong operational metrics included a bed occupancy rate of 75% and free treatments provided to over 38,000 patients from economically weaker sections.

For the nine months ended December 2024, total network revenues reached INR 6,636 Cr, a 25% increase YoY, with net debt standing at INR 1,608 Cr. The outcomes demonstrate operational efficiency and a positive outlook for sustainable growth, warranting investor attention.